LeMaitre Vascular, Inc. (LMAT) vs Palvella Therapeutics, Inc. (PVLA)
A side-by-side comparison of LeMaitre Vascular, Inc. and Palvella Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LMAT
LeMaitre Vascular, Inc.
$79.47HealthcareDelayed quote: Oct 6, 2026, 2:38 PM EDT
PVLA
Palvella Therapeutics, Inc.
$130.52HealthcareDelayed quote: Oct 6, 2026, 2:39 PM EDT
Total return — LMAT vs PVLA
growth of $100 · dividends reinvested · last 2yLMAT -21.5% (-11.4%/yr)PVLA +677.4% (+178.8%/yr)PVLA compounded faster over this window
Log scale — wide-divergence pair
LMAT PVLA
LMAT vs PVLA: by the numbers
- •PVLA is the larger company ($1.87B vs $1.82B market cap).
- •LMAT is profitable (25.02% net margin) while PVLA runs a net loss (0.00%).
- •LMAT pays a dividend (1.17% yield), while PVLA has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | LMAT | PVLA |
|---|---|---|
| P/E ratio | 27.88 | N/A |
| Forward P/E | 27.66 | N/A |
| PEG ratio | 1.44 | N/A |
| P/S ratio | 6.92 | N/A |
| P/B ratio | 4.32 | 8.63 |
| EV / EBITDA | 21.78 | N/A |
| FCF yield | 4.07% | N/A |
Profitability
| Metric | LMAT | PVLA |
|---|---|---|
| Gross margin | 72.90% | 0.00% |
| Operating margin | 29.46% | 0.00% |
| Net margin | 25.02% | 0.00% |
| ROE | 15.62% | -28.45% |
| ROIC | 9.81% | -23.90% |
Dividends
| Metric | LMAT | PVLA |
|---|---|---|
| Dividend yield | 1.17% | N/A |
| Payout ratio | 33.33% | N/A |
Growth (annualized)
| Metric | LMAT | PVLA |
|---|---|---|
| Revenue CAGR (5Y) | 11.76% | N/A |
| EPS CAGR (5Y) | 19.42% | N/A |
| FCF CAGR (5Y) | 13.06% | N/A |
| Total return CAGR (5Y) | 9.79% | N/A |
Frequently asked
- Does LMAT or PVLA pay a bigger dividend?
- LMAT pays a dividend (1.17% yield), while PVLA has no payments in the available dividend history.
- Is LMAT or PVLA more profitable?
- LMAT runs the higher net margin — LMAT at 25.02% versus PVLA at 0.00%.
Go deeper
Dig into the metrics
LeMaitre Vascular P/E ratioLeMaitre Vascular dividend yieldLeMaitre Vascular ROEPalvella Therapeutics ROELeMaitre Vascular operating marginPalvella Therapeutics operating marginLeMaitre Vascular revenue growthPalvella Therapeutics revenue growthLeMaitre Vascular free cash flowPalvella Therapeutics free cash flow
LeMaitre Vascular & Palvella Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.